A variety of tools have been used to assess the severity of plaque psoriasis and response to treatment, some of which are detailed above. The PASI, which provides a measure of the average redness, thickness and scaliness of the lesions, is the current gold standard for assessing response to treatment.
-
Discovered and developed by Centocor, ustekinumab (CNTO 1275) is an... -
Studies conducted to date suggest that ustekinumab is an effective treatment... -
A variety of tools have been used to assess the severity of plaque psoriasis...
